Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7332 p40
15 January 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Limiting vitamin A intake may be desirable for some

People who are at risk of bone fractures and those who eat liver regularly may be advised to limit their intake of vitamin A.

A draft report (PDF 560K) published by the Government’s Scientific Advisory Committee on Nutrition concludes that post-menopausal women and older people should not consume more than 1.5mg of vitamin A each day. It also recommends that people who eat liver regularly (once a week or more) should not increase this amount and should not take supplements containing vitamin A.

The committee was asked by the Food Standards Agency to examine data relating to the suggestion that high intakes of vitamin A may increase the risk of bone fractures in the long term. It found insufficient evidence to justify a change in dietary advice to all consumers but highlighted the groups of people for which precautionary measures may be sensible.

Peter Aggett, a member of the SACN, said: “Our initial conclusions are that although there is insufficient evidence on the relationship between vitamin A and bone health to warrant a change in advice to all consumers, it may be advisable for some population groups to limit their vitamin A intakes. The report will be reviewed in light of any comments received or new research and we will then present our final conclusions to the FSA later this year.”

The draft report is available online (PDF 560K).

Chromium picolinate Advice about the dietary supplement chromium picolinate has also been updated. The Food Standards Agency has revised its earlier recommendation that chromium picolinate should be avoided because of safety concerns (PJ, 17 May 2003, p671), now stating that the supplement is safe. A review by the Committee on Mutagenicity (an independent committee that advises the FSA and Department of Health) has concluded that earlier suggestions that chromium picolinate might be genotoxic are not backed up by available evidence.

Back to Top


©The Pharmaceutical Journal